The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but rather one of its longest standing companies. While many biotech stocks have struggled this year ...

Biotech leaders have been warning about this washout, and small companies across the country, including in Boston, have already resorted to layoffs or dropped experimental drug programs to buy ...

The greater Boston area is home to close to one thousand biotech companies. While Boston has long been a center of the life sciences, it has largely expanded thanks to huge government investments ...

“Lots of companies are limping along,” said Mani Foroohar, senior research analyst at Boston health care investment bank Leerink Partners. Foroohar, a top biotech analyst, has slapped an ...

Insider asked 12 venture capitalists which biotech startups would take off in the next year. Here are the 10 startups they named that are located in the Boston area. They're attempting to ...

The slowdown has caused pain this year for companies from biotech startups to spec developers, but experts say the Boston market still has strong fundamentals and they are optimistic it will ...

Nowhere near the stratosphere of Boston. All these factors make it ... Fujifilm is one of several big biotech companies that have moved to Holly Springs, a growing town about a half hour from ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

The Boston-based cell programming and biosecurity company had said the cuts were coming during quarterly earnings call earlier this year. Ginkgo Bioworks Holdings Inc. is headquartered in the ...

A few weeks after releasing disappointing data from its norovirus vaccine trial, a Boston biotech is cutting its workforce. A few weeks after releasing disappointing data from its norovirus ...

The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but rather one of its longest standing companies. While many biotech stocks have struggled this year ...